Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction

Molecular and Cellular Biochemistry

Volumn 182, Issue 1-2, 1998, Pages 101-108

  Byon, John C H ^a   Kusari, Anasua B ^a   Kusari, Jyotirmoy ^a,b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Diabetes; Insulin action; PTP 1B

Indexed keywords

INSULIN; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; DEPHOSPHORYLATION; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ENZYME ACTIVATION; HUMANS; INSULIN; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 0031941815     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006868409841     Document Type: Article

References (51)

1. Kasuga M, Karlsson FA, Kahn CR: Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science 215: 185-187, 1982
2. Kahn CR, White MF, Shoelson SE, Backer JM, Araki E, Cheatham B, Csermely P, Folli F, Goldstein BJ, Huertas P, Rothenberg PL, Saad MJA, Siddle K, Sun X-J, Wilden PA, Yamada K, Kahn SA: The insulin receptor and its substrate: molecular determinants of early events in insulin action. Rec Prog Horm Res 48: 291-339, 1993
3. Rosen OM: After insulin binds. Science 237: 1452-1458, 1987
4. Cheatham B, Kahn CR: Insulin action and the insulin signaling network. Endo Rev 16: 117-142, 1995
5. Kahn CR, White MF: The insulin receptor and the molecular mechanism of insulin action. J Clin Invest 82: 1151-1156, 1988
6. Olefsky JM: The insulin receptor. A multifunctional protein. Diabetes 39: 1009-1016, 1990
7. Goldfine ID: The insulin receptor: Molecular biology and transmembrane signaling. Endo Rev 8: 235-255, 1987
8. Tonks NK, Diltz CD, Fischer EH: Purification of the major protein-tyrosine phosphatase of human placenta. J Biol Chem 263: 6722-6730, 1988
9. Tonks NK, Diltz CD, Fischer EH: Characterization of the major protein-tyrosine phosphatase of human placenta. J Biol Chem 263: 6731-6737, 1988
10. Charbonneau H, Tonks NK, Kumar S, Diltz CD, Harrylock M, Cool DE, Krebs EG, Fisher EH: Human placenta protein-tyrosine phosphatase: Amino-acid sequence and relationship to a family of receptor-like proteins. Proc Natl Acad Sci USA 86: 5152-5256, 1990
11. Streuli M, Drueger NX, Thai T, Tang M, Saito H: Distinct functional roles of the two intracellular phosphatase like domains of the receptor-linked protein-tyrosine phosphatases LCA and LAR. EMBO 19: 2399-2407, 1990
12. Guan KL, Huan RS, Watson SJ, Geahlen RL, Dixon JE: Cloning and expression of a protein-tyrosine phosphatase. Proc Natl Acad Sci USA 87: 1501-1505, 1991
13. Guan KL, Dixon JE: Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate. J Biol Chem 266: 17026-17030, 1991
14. Kenner KA, Hill DE, Olefsky JM, Kusari J: Regulation of protein tyrosine phosphatases by insulin and insulin-like growth factor 1. J Biol Chem 268: 25455-25462, 1993
15. Cicirelli MF, Tonks NK, Diltz CD, Weiel JE, Fischer EH, Krebs EG: Microinjection of a protein-tyrosine phosphatase inhibits insulin action in Xenopus oocytes. Proc Natl Acad Sci USA 87: 5514-5518, 1990
16. r-human placenta protein tyrosine phosphatase on induction of meiotic cell division in Xenopus oocytes. Mol Cell Biol 10: 458-463, 1990
17. Kenner KA, Hill DE, Olefsky JM, Kusari J: Protein-tyrosine phosphatase 1B is a negative regulator of insulin and insulin-like growth factor-1-stimulated signaling. J Biol Chem 271: 19810-19816, 1996
18. Ahmad F, Li PM, Meyerovitch J, Goldstein BJ: Osmotic loading of neutralizing anitbodies demonstrates a role for protein tyrosine phosphatase 1B in negative regulation of the insulin action pathway. J Biol Chem 270: 20503-20508, 1996
19. Liotta AS, Kole HK, Fales HM, Roth J, Bemier M: A synthetic tris-sulfotyrosyl dodecapeptide analogue of the insulin receptor 1146-kinase domain inhibits tyrosine dephosphorylation of the insulin receptor in situ. J Biol Chem 269: 22996-23001, 1994
20. Chen H, Wertheimer SJ, Lin CH, Katz SL, Amrein KE, Bum P, Quon MJ: Protein-tyrosine phosphatases PTP-1B and Syp are modulators of insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. J Biol Chem 272: 8026-8031, 1997
21. Seely BL, Staubs PA, Reichart DR, Berhanu P, Milarski KL, Saltiel AR, Kusari J, Olefsky JM: Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes 45: 1379-1385, 1996
22. Bandyopadhyay D, Kusari A, Kenner KA, Liu F, Chernoff J, Gustafson TA, Kusari J: Protein tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine phosphorylated in the presence of insulin. J Biol Chem 272: 1639-1645, 1997
23. Pearson RB, Kemp BE: Design and use of peptide substrates for protein kinases. In: T Hunter, BM Setton (eds). Methods in Enzymology. Academic Press, New York, Vol. 200 (Part A), 1991, pp 62-81
24. Mayer BJ, Jackson PK, Van Etten RA, Baltimore D: Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo. Mol Cell Biol 12: 609-618, 1992
25. Koch CA, Anderson D, Moran MF, Ellis C, Pawson T: SH2 and SH3 domains: Elements that control interactions of cytoplasmic signaling proteins. Science 252: 668-674, 1991
26. Kusari J, Bandhyopadhay D, Kenner K, Kusari A: Activated insulin receptor phosphorlyates and increases the catalytic activity of protein tyrosine phosphatase 1B (PTPase 1B). Diabetes 46(Suppl. I): (abstr) 204A, 1997
27. Stein-Gerlach M, Kharitonenkov A, Vogel W, Ali S, Ullrich A: Protein-tyrosine phosphatase ID modulates its own state of tyrosine phosphorylation. J Biol Chem 270: 24635-24637, 1995
28. Olefsky JM: Pathogenesis of non-insulin-dependent diabetes (type II). In: LJ Degroot, GM Besser, GF Cahill, JC Marshall, DH Nelson, WD Odell, JT Potts, AH Rubenstein Jr, E Steinberger (eds). Endocrinology. 2nd ed. W.B. Saunders Co., Philadelphia, USA, 1989, pp 1369-1388
29. Kolertman OG, Gray RS, Griffin J, Burstein P, Insel J, Scarlett JA, Olefsky JM: Receptor and post-receptor defects contribute to the insulin resistance in non-insulin-dependent diabetes mellitus. J Clin Invest 68: 957-969, 1981
30. Truglia JA, Livingston JN, Lockwood DH: Insulin resistance: Receptor and post-binding defects in human obesity and non-insulin-dependent diabetes mellitus. Am J Med 79 (Suppl 2B): 13-21, 1985
31. Freidenberg GR, Henry RR, Klein HH, Reichart HH, Olefsky JM: Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. J Clin Invest 79: 240-250, 1987
32. Sinha MK, Poires WJ, Flickinger EG, Meelheim D, Caro JF: Insulin-receptor kinase activity of adipose tissue from morbidly obese humans with and without NIDDM. Diabetes 36: 620-625, 1987
33. Caro JF, Ittoop O, Pories WJ, Meelheim D, Flickinger EG, Thomas F, Jenquin JF, Silverman JF, Khazanie PG, Sinha MK: Studies on the mechanism of insulin resistance in the liver from humans with non insulin-dependent diabetes. J Clin Invest 78: 249-258, 1986
34. Caro JF, Sinha MK, Raju SM, Ittoop O, Pories WJ, Flickinger EG, Meelheim D, Dohm GL: Insulin receptor kinase in human skeletal muscle from obese subjects with and without non insulin-dependent diabetes. J Clin Invest 79: 1330-1337, 1987
35. Ahmad F, Goldstein BJ: Alterations in specific protein-tyrosine phosphatases accompany insulin resistance of streptozotocin diabetes. Am J Physiol 268: E932-E940, 1995
36. Ahmad F, Goldstein BJ: Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus. Metabolism 44: 1175-1184, 1995
37. Olichon-Berthe C, Hauguel-De Mouzon S, Peraldi P, Van Obberghen E, Le Marchand-Brustel Y: Insulin receptor dephosphorylation by phosphotyrosine phosphatases obtained from insulin-resistant obese mice. Diabetologia 37: 56-60, 1994
38. McGuire MC, Fields RM, Nyomba BL, Raz I, Bogardus C, Tonks NK, Sommercorn J: Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin resistant humans. Diabetes 40: 939-942, 1991
39. Kusari J, Kenner KA, Suh K-Y, Hill DE, Henry RR: Skeletal muscle protein-tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance. J Clin Invest 93: 1156-1162, 1994
40. Worm D, Vinten J, Staehr P, Henriksen JE, Handberg A, Beck-Nielsen H: Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects. Diabetologia 39: 1208-1214, 1996
41. Olefsky JM, Garvey WT, Henry RR, Brillan D, Matthaei S, Freidenberg GR: Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes. Am J Med 85: 86-105, 1988
42. Frangloni JV, Beahm PH, Shifrin V, Jost CA, Neel BG: The non-transmembrane tyrosine phosphatase FTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-tenninal sequence. Cell 68: 545-560, 1992
43. Maegawa H, Ide R, Hasegawa M, Ugi S, Egawa D, Iwanishi M, Kikkawa R, Shigeta Y, Kashiwagi A: Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities. J Biol Chem 270: 7724-7730, 1995
44. Faure R, Baquiran G, Bergeron JJ, Posner BI: The dephosphorylation of the insulin and epidermal growth factor receptors. Role of endosome-associated phosphotyrosine phosphatases. J Biol Chem 267: 11215-11221, 1992
45. Burgess JW, Wadal, Ling N, Khan MN, Bergeron JJ, Posner BI: Decrease in beta-subunit phosphotyrosine correlates with internalization and activation of the endosomal insulin receptor kinase. J Biol Chem 267: 10077-10086, 1992
46. Yu H, Chen JK, Feng S, Dalgamo DC, Brauer AW, Schreiber S: Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76: 933-945, 1994
47. Feng S, Chen JK, Yu H, Simon JA, Schreiber S: Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science 266: 1241-1247, 1994
48. Cas. J Biol Chem 271: 31290-31295, 1996
49. Flint AJ, Tiganis T, Barford D, Tonks NK: Development of 'substrate-trapping' mutants to identify physiological substrates of protein tyrosine phosphatases. Proc Natl Acad Sci USA 94: 1680-1685, 1997
50. Barford D, Flint AJ, Tonks NK: Crystal structure of human protein tyrosine phosphatase 1B. Science 263: 1397-1404, 1994
51. Jia Z, Barford D, Flint AJ, Tonks NK: Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B. Science 268: 1754-1758, 1995